Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study Sakiko TeruiMari IgariJun Shirakawa Original Research Open access 18 March 2024 Pages: 1139 - 1153
Efficacy and Safety of Tirzepatide in Patients with Type 2 Diabetes: Analysis of SURPASS-AP-Combo by Different Subgroups Yan BiSong LuLinong Ji Original Research Open access 18 March 2024 Pages: 1125 - 1137
Insulin Use During Gestational and Pre-existing Diabetes in Pregnancy: A Systematic Review of Study Design Kristin CastorinoBeatrice OsumiliCarolina Piras de Oliveira Review Open access 18 March 2024 Pages: 929 - 1045
The Implication of Diabetes-Specialized Nurses in Aiming for the Better Treatment and Management of Patients with Diabetes Mellitus: A Brief Narrative Review Yefang ZhuHongmei ZhangHong Lei Review Open access 12 March 2024 Pages: 917 - 927
Expert Opinion on Current Trends in the Use of Insulin in the Management of People with Type 2 Diabetes from the South-Eastern European Region and Israel Adam G. TabakPeter KemplerBoris Mankovsky Review Open access 12 March 2024 Pages: 897 - 915
Insulin Degludec in People with Type 2 Diabetes in China: A Non-interventional, Retrospective Chart Review Study (CN-TREAT) Weimin WangXiangyun ChangDalong Zhu Original Research Open access 05 March 2024 Pages: 725 - 739
Real-World Use of Oral and Subcutaneous Semaglutide in Routine Clinical Practice in the UK: A Single-Centre, Retrospective Observational Study Sharmistha Roy ChowdhuryFethi SadoukiStephen C. Bain Brief Report Open access 01 March 2024 Pages: 869 - 881
Glycemic and Cost Outcomes among Hispanic/Latino People with Type 2 Diabetes in the USA Initiating Dulaglutide versus Basal Insulin: a Real-World Study Meredith HoogJuan M. MaldonadoManige Konig Original Research Open access 01 March 2024 Pages: 855 - 867
Impact of Glucagon-Like Peptide 1 Agonist Deprescription in Type 2 Diabetes in a Real-World Setting: A Propensity Score Matched Cohort Study Amy L. McKenzieShaminie J. Athinarayanan Original Research Open access 29 February 2024 Pages: 843 - 853
Publisher Correction: Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model Hiroaki IijimaHidetoshi ShimizuTakashi Kadowaki Publisher Correction Open access 29 February 2024 Pages: 779 - 780
Cardiovascular Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Diabetes: A Real-World Data Analysis Jonathan Y. M. LaiDavid R. RileyUazman Alam Original Research Open access 24 February 2024 Pages: 833 - 842
Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered Orforglipron (LY3502970), a Non-peptide GLP-1 Receptor Agonist Xiaosu MaRong LiuKyle W. Sloop Original Research Open access 24 February 2024 Pages: 819 - 832
Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study Kazuo HaraTetsuaki HiraseRyo Takemura Original Research Open access 24 February 2024 Pages: 801 - 817
Comparative Efficacy and Safety of Tirzepatide in Asians and Non-Asians with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis Yuying CuiJinming YaoLin Liao Original Research Open access 24 February 2024 Pages: 781 - 799
Personalized Versus Non-personalized Nutritional Recommendations/Interventions for Type 2 Diabetes Mellitus Remission: A Narrative Review Ana T. Arias-MarroquínFabiola M. Del Razo-OlveraCarlos A. Aguilar-Salinas Review Open access 20 February 2024 Pages: 749 - 761
Impact of Participant Characteristics on Clinical Outcomes with iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of SPARTA Japan Daisuke YabeMunehide MatsuhisaYasuo Terauchi Original Research Open access 16 February 2024 Pages: 705 - 723
Menopausal Hormone Therapy in Women with Type 2 Diabetes Mellitus: An Updated Review Stavroula A. PaschouKleoniki I. AthanasiadouNikolaos Papanas Review Open access 16 February 2024 Pages: 741 - 748
Protocol of a Prospective Observational Study on Lifestyle and Quality of Life in Adults with Type 1 Diabetes in Japan Junko SatoKenichi NakajimaHirotaka Watada Study Protocol Open access 15 February 2024 Pages: 883 - 892
Real-World Study on Effectiveness of Insulin Glargine U300 After Oral Antidiabetic Drug Failure in Patients with Type 2 Diabetes in the Gulf Region Niaz E. KhanAbdulRahman A. M. Al ShaikhYasser A. Akil Original Research Open access 15 February 2024 Pages: 691 - 704
Identifying Ontarians with Type 2 Diabetes Mellitus in Administrative Data: A Comparison of Two Case Definitions Robyn L. HouldenNilasha ThayalanAiden Liu Original Research Open access 10 February 2024 Pages: 677 - 689
Risk of Dementia in Patients with Diabetes Using Sodium-Glucose Transporter 2 Inhibitors (SGLT2i): A Systematic Review, Meta-Analysis, and Meta-Regression Pricilla Yani GunawanPaskalis Andrew GunawanTimotius Ivan Hariyanto Original Research Open access 10 February 2024 Pages: 663 - 675
Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc Analysis Yukiko OnishiTomonori OuraMasakazu Takeuchi Original Research Open access 04 February 2024 Pages: 649 - 661
Treat Obesity to Treat Type 2 Diabetes Mellitus Cem SuluVolkan Demirhan Yumuk Review Open access 04 February 2024 Pages: 611 - 622
A Narrative Review of Diabetic Macroangiopathy: From Molecular Mechanism to Therapeutic Approaches Jiacheng YinXiaoxu FuChunguang Xie Review Open access 02 February 2024 Pages: 585 - 609
Association Between Adherence, A1C Improvement, and Type of Continuous Glucose Monitoring System in People with Type 1 Diabetes or Type 2 Diabetes Treated with Intensive Insulin Therapy Poorva M. NemlekarKatia L. HannahGregory J. Norman Original Research Open access 30 January 2024 Pages: 639 - 648
Therapeutic Inertia in the Management of Type 2 Diabetes: A Narrative Review Paloma RodriguezVicente T. San MartinKevin M. Pantalone Review Open access 25 January 2024 Pages: 567 - 583
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study Anastas KickKhadija M’Rabet-BensalahGottfried Rudofsky Original Research Open access 19 January 2024 Pages: 623 - 637
Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as Metformin Add-on in a Korean Population with Type 2 Diabetes Byung-Wan LeeYoung Min ChoJae Myung Yu Original Research Open access 18 January 2024 Pages: 547 - 563
Emotional, Psychological, and Social Well-being Experience of Long-Term Living with Type 1 Diabetes Mellitus: A Patient–Psychiatrist–Endocrinologist Perspective Mohammed Najeeb AshrafAlice Y. Y. ChengDavid J. Robinson Commentary Open access 17 January 2024 Pages: 317 - 323
Impact of Living with Stigma in Persons with Type 1 Diabetes: A Patient–Physician Perspective Mohammed Najeeb AshrafAlice Y. Y. Cheng Commentary Open access 16 January 2024 Pages: 311 - 316
A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01) Yushi HirotaYasumasa KakeiWataru Ogawa Original Research Open access 13 January 2024 Pages: 533 - 545
A Podcast on the Use of CGM in Optimizing Type 2 Diabetes Management with Non-intensive Insulin Treatment in the Primary Care Setting Samuel Seidu Commentary Open access 13 January 2024 Pages: 301 - 309
A Systematic Literature Review of Psychological Interventions for Adults with Type 1 Diabetes Onyinye DiribeKaren PalmerMike Baxter Review Open access 06 January 2024 Pages: 367 - 380
The Effect of Sodium–Glucose Cotransporter Inhibitors on Renal Function as Adjunctive to Insulin in Adults with Type 1 Diabetes: An Updated Multilevel Meta-analysis of Randomized Controlled Trials Paschalis KarakasisDjordje S. PopovicManfredi Rizzo Original Research Open access 05 January 2024 Pages: 521 - 532
Glycemic Control, Weight Management, Cardiovascular Safety, and Cost-Effectiveness of Semaglutide for Patients with Type 2 Diabetes Mellitus: A Rapid Review and Meta-analysis of Real-World Studies Sihua WangSheng WangJiajie Luan Original Research Open access 04 January 2024 Pages: 497 - 519
Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Added to Dual or Triple Treatment in Patients with Type 2 Diabetes Mellitus Yesol HongYoomin JeonHoward Lee Original Research Open access 20 December 2023 Pages: 487 - 496
Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model Hiroaki IijimaHidetoshi ShimizuTakashi Kadowaki Original Research Open access 20 December 2023 Pages: 763 - 777
Evaluating the Clinical Effectiveness and Safety of Semaglutide in Individuals with Uncontrolled Type 2 Diabetes. Real-World Evidence from Saudi Arabia: The Observational, Multicenter, 15-Month EVOLUTION Study Abdulrahman AlsheikhAli AlshehriSaud Alsifri Original Research Open access 19 December 2023 Pages: 473 - 485
Maternal Height Is an Independent Risk of Adverse Outcomes in Women with Gestational Diabetes Mellitus Mengkai DuMarie Parfaite Uwimana MuhuzaZhaoxia Liang Original Research Open access 17 December 2023 Pages: 461 - 472
Evaluation of System Accuracy, Precision, Hematocrit Influence, and User Performance of Two Blood Glucose Monitoring Systems Based on ISO 15197:2013/EN ISO 15197:2015 Stefan PleusNina JendrikeGuido Freckmann Original Research Open access 15 December 2023 Pages: 447 - 459
Durability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (DPP–4i) in US Adults with Type 2 Diabetes Xi TanYuanjie LiangAaron King Original Research Open access 07 December 2023 Pages: 427 - 445
Correction to: Is the Current Cut Point for Glycated Haemoglobin (HbA1c) Correct for Diagnosing Diabetes Mellitus in Premenopausal Women? Evidence to Inform Discussion David HollandAnthony A. FryerPensee Wu Correction Open access 01 December 2023 Pages: 565 - 566
Impact of Weight Change on Glycemic Control and Metabolic Parameters in T2D: A Retrospective US Study Based on Real-World Data Shraddha ShindeVivian Thuyanh ThieuDavid Schapiro Original Research Open access 01 December 2023 Pages: 409 - 426
An Economic Evaluation of the Relationship Between Glycemic Control and Total Healthcare Costs for Adults with Type 2 Diabetes: Retrospective Cohort Study Kristina S. BoyeJay P. BaeMaureen J. Lage Original Research Open access 01 December 2023 Pages: 395 - 407
Safety, Metabolic and Psychological Outcomes of Medtronic MiniMed 780G™ in Children, Adolescents and Young Adults: A Systematic Review Stefano PassanisiFortunato LombardoMaurizio Delvecchio Review Open access 01 December 2023 Pages: 343 - 365
Disease and Economic Burden of Poor Metabolic and Weight Control in Type 2 Diabetes in Spain: A Systematic Literature Review Antonio PérezJennifer Redondo-AntónDomingo Orozco-Beltrán Review Open access 22 November 2023 Pages: 325 - 341
Physician Perceptions of Dose Escalation for Type 2 Diabetes Medications in the United States Kristina S. BoyeJessica B. JordanLouis S. Matza Original Research Open access 18 November 2023 Pages: 381 - 393
Telehealth Use and Healthcare Utilization Among Individuals with Type 2 Diabetes During the COVID-19 Pandemic: Evidence From Louisiana Medicaid Claims Yixue ShaoLizheng ShiCharles Stoecker Original Research Open access 17 November 2023 Pages: 229 - 243
The International Working Group on the Diabetic Foot: Stories and Numbers Behind Three Decades of Evidence-Based Guidelines for the Management of Diabetes-Related Foot Disease Jaap J. van NettenJan ApelqvistNicolaas C. Schaper Commentary Open access 16 November 2023 Pages: 19 - 31
Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review Anca Pantea StoianIoana-Cristina BicaThe Cardiometabolic Panel of International Experts on Syndemic COVID-19 (CAPISCO) Correction Open access 15 November 2023 Pages: 297 - 299
